newsfilter
← Latest News
Business Wire·

Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2026 Financial Results

Presentations at AACR Annual Meeting 2026 underscore significant opportunities for nuzefatide pevedotin in EphA2 expressing cancers, including pancreatic cancer Human imaging data provides further evidence of the